Mas and Inflammation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-801364-9.00030-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling.

  2014cited by this paper
• Centrally administered angiotensin‐(1–7) increases the survival of stroke‐prone spontaneously hypertensive rats

  2014cited by this paper
• The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.

  2014cited by this paper
• Receptor Mas Protects Mice Against Hypothermia and Mortality Induced By Endotoxemia

  2014cited by this paper
• Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.

  2013cited by this paper
• Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury.

  2013cited by this paper
• Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury

  2013cited by this paper
• Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling.

  2013cited by this paper
• Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet.

  2013cited by this paper
• Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy

  2013cited by this paper
• ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis

  2013cited by this paper
• AVE 0991, a non‐peptide mimic of angiotensin‐(1–7) effects, attenuates pulmonary remodelling in a model of chronic asthma

  2013cited by this paper
• Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice.

  2013cited by this paper
• Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.

  2012cited by this paper
• Angiotensin‐(1–7) decreases LPS‐induced inflammatory response in macrophages

  2012cited by this paper
• Suppressing inflammation by inhibiting the NF‐κB pathway contributes to the neuroprotective effect of angiotensin‐(1‐7) in rats with permanent cerebral ischaemia

  2012cited by this paper
• Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats

  2012cited by this paper
• Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐ and NF‐κB‐dependent pathways

  2012cited by this paper
• Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats.

  2012cited by this paper
• Nonclassical renin-angiotensin system and renal function.

  2012cited by this paper
• Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury

  2012cited by this paper
• Angiotensin signalling in pulmonary fibrosis.

  2012cited by this paper
• Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart.

  2012cited by this paper
• ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production

  2012cited by this paper
• Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats.

  2012cited by this paper
• Role of renin-angiotensin system in inflammation, immunity and aging.

  2012cited by this paper
• Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.

  2012cited by this paper
• ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

  2011cited by this paper
• Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis

  2011cited by this paper
• Contributions of ACE and mast cell chymase to endogenous angiotensin II generation and leucocyte recruitment in vivo.

  2011cited by this paper
• Anti-Inflammatory Effects of the Activation of the Angiotensin-(1–7) Receptor, Mas, in Experimental Models of Arthritis

  2010cited by this paper
• Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation

  2010cited by this paper
• Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

  2010cited by this paper
• The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

  2010cited by this paper
• Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status

  2010cited by this paper
• Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse

  2010cited by this paper
• Angiotensin‐converting‐enzyme 2 inhibits liver fibrosis in mice

  2009cited by this paper
• Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction

  2009cited by this paper
• Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits.

  2009cited by this paper
• Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

  2009cited by this paper
• Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.

  2009cited by this paper
• Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

  2009cited by this paper
• Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer

  2009cited by this paper
• Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis.

  2008cited by this paper
• Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression

  2008cited by this paper
• Candesartan Ameliorates Cardiac Dysfunction Observed in Angiotensin-Converting Enzyme 2-Deficient Mice

  2008cited by this paper
• Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology

  2008cited by this paper
• ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages.

  2008cited by this paper
• Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells

  2007cited by this paper
• The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).

  2007cited by this paper
• CXCR2 Blockade Impairs Angiotensin II–Induced CC Chemokine Synthesis and Mononuclear Leukocyte Infiltration

  2007cited by this paper
• Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.

  2007cited by this paper
• Cardiovascular-Renal Mechanisms in Health and Disease Prevention of angiotensin II-induced cardiac remodeling by angiotensin-( 1 – 7 )

  2007cited by this paper
• Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

  2006cited by this paper
• Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

  2006cited by this paper
• Angiotensin II-Induced Mononuclear Leukocyte Interactions with Arteriolar and Venular Endothelium Are Mediated by the Release of Different CC Chemokines1

  2006cited by this paper
• Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload–Induced Cardiac Dysfunction by Increasing Local Angiotensin II

  2006cited by this paper
• Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.

  2005cited by this paper
• Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats

  2005cited by this paper
• Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.

  2005cited by this paper
• Inhibition of human lung cancer cell growth by angiotensin-(1-7).

  2004cited by this paper
• Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines

  2004cited by this paper
• Inflammation and angiotensin II.

  2003cited by this paper
• Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)

  2003cited by this paper
• Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension.

  2002cited by this paper
• Angiotensin II is involved in nitric oxide synthase and cyclo‐oxygenase inhibition‐induced leukocyte‐endothelialcell interactions in vivo

  2001cited by this paper
• Proinflammatory actions of angiotensins

  2001cited by this paper
• Angiotensin II Induces Leukocyte–Endothelial Cell Interactions In Vivo Via AT1 and AT2 Receptor–Mediated P-Selectin Upregulation

  2000cited by this paper

• Analytical Methods and Effects of Bioactive Peptides Derived from Animal Products: A Mini-Review

  2024cites this paper
• 20-Hydroxyecdysone activates the protective arm of the renin angiotensin system via Mas receptor

  2020cites this paper